<DOC>
	<DOCNO>NCT01549483</DOCNO>
	<brief_summary>The purpose study study difference small airway ( &lt; 2mm ) parameter asthma patient , subject asymptomatic airway hyperresponsiveness healthy control .</brief_summary>
	<brief_title>Small Airways Disease Asymptomatic Symptomatic Subjects With Airway Hyperresponsiveness ( AHR )</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Hypersensitivity</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Inclusion criterion asymptomatic subject airway hyperresponsiveness ( AHR ) : Age 18 65 year . Forced expiratory volume one second ( FEV1 ) &gt; 80 % predict post bronchodilator . Provocative concentration cause 205 fall FEV1 ( PC20 ) methacholine &lt; 8 mg/ml . No history asthma previous use asthma medication . Inclusion criterion asymptomatic subject without AHR : Age 18 65 year . FEV1 &gt; 80 % predict post bronchodilator . PC20 methacholine &gt; 8 mg/ml . No history asthma previous use asthma medication . Inclusion criteria patient asthma : Age 18 65 year . FEV1 &gt; 80 % predict . PC20 methacholine â‰¤8 mg/ml . Doctor 's diagnosis asthma . No history Chronic obstructive pulmonary disease ( COPD ) . Use inhale oral steroid , antihistamine , nedocromil , theophylline , leukotrien antagonist longacting betaagonists least three week start study . Any disease may affect outcome study judge Investigator . FEV1 &lt; 1.2 liter .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>asthma</keyword>
	<keyword>airway hyperresponsiveness</keyword>
	<keyword>asymptomatic airway hyperresponsiveness</keyword>
	<keyword>small airway</keyword>
</DOC>